Effects of Laser-assisted Periodontal Flap Surgery on Inflammatory Cytokines and Clinical Outcomes in Periodontitis

Authors

  • Ya Hu Department of Stomatology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology, The Second Clinical Medical College, Jinan University), Shenzhen, China
  • Lanlan Zhu School of Clinical Medicine, Chongqing Medical and Pharmaceutical College, Chongqing, China
  • Hanyan Li Department of Stomatology, Zhuanqiao Community Health Service Center, Shanghai, China

DOI:

https://doi.org/10.18502/ijaai.v25i6.22648

Keywords:

Clinical attachment level; Inflammatory factors; Laser therapy; Periodontal flap surgery; Probing depth; Stage 3–4 periodontitis

Abstract

The aim of this study was to evaluate the clinical and inflammatory outcomes of minocycline hydrochloride combined with tinidazole in patients with chronic periodontitis.

PubMed, Cochrane Library, Embase, CNKI, WanFang Data, and VIP were searched through December 2025 for randomized and nonrandomized controlled studies. Randomized trials were assessed using the Cochrane Risk of Bias tool, while the cohort study was assessed using ROBINS-I. Meta-analysis was conducted using RevMan 5.3. Random-effects models were applied when substantial heterogeneity was present, and sensitivity analyses were performed by excluding the cohort study.

Fourteen studies were included. Compared with the control treatment, combination therapy was associated with greater improvements in gingival index (MD=−0.71; 95% CI, −0.77 to −0.65), probing pocket depth (MD=−0.87; 95% CI, −1.07 to −0.66), clinical attachment level (MD=−0.77; 95% CI, −1.06 to −0.49), plaque index (MD=−0.38; 95% CI, −0.45 to −0.32), and sulcus bleeding index (MD=−0.68; 95% CI, −0.96 to −0.40). Changes were also observed in several inflammatory and immune-related indicators, whereas CRP did not differ significantly between the groups. Substantial heterogeneity was present for most outcomes.

Overall, minocycline hydrochloride combined with tinidazole may provide additional short-term benefits for patients with chronic periodontitis. Nevertheless, these findings should be interpreted cautiously because of methodological limitations, substantial heterogeneity, incomplete safety reporting, and short follow-up periods.

Published

2026-09-15

Issue

Section

Articles